These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 26760586)

  • 1. What's new in the pathogenesis of the coagulopathy in acute promyelocytic leukemia?
    Mantha S; Tallman MS; Soff GA
    Curr Opin Hematol; 2016 Mar; 23(2):121-6. PubMed ID: 26760586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in the management of coagulopathy in acute promyelocytic leukemia.
    Sanz MA; Montesinos P
    Thromb Res; 2020 Jul; 191 Suppl 1():S63-S67. PubMed ID: 32736781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors in acute promyelocytic leukemia: strategies to define high-risk patients.
    Testa U; Lo-Coco F
    Ann Hematol; 2016 Apr; 95(5):673-80. PubMed ID: 26920716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
    Rolovitsh Z; Cholovitsh M; Elezovitsh I; Vidovitsh A; Radoshevitsh-Radojkovitsh N; Boshkovitsh D; Novak A; Basara N
    Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant human soluble thrombomodulin safely and effectively rescues acute promyelocytic leukemia patients from disseminated intravascular coagulation.
    Ikezoe T; Takeuchi A; Isaka M; Arakawa Y; Iwabu N; Kin T; Anabuki K; Sakai M; Taniguchi A; Togitani K; Yokoyama A
    Leuk Res; 2012 Nov; 36(11):1398-402. PubMed ID: 22917769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New insights into the pathogenesis of coagulation dysfunction in acute promyelocytic leukemia.
    Tallman MS; Hakimian D; Kwaan HC; Rickles FR
    Leuk Lymphoma; 1993 Sep; 11(1-2):27-36. PubMed ID: 8220153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The coagulopathy of acute promyelocytic leukaemia revisited.
    Stein E; McMahon B; Kwaan H; Altman JK; Frankfurt O; Tallman MS
    Best Pract Res Clin Haematol; 2009 Mar; 22(1):153-63. PubMed ID: 19285282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombo-hemorrhagic deaths in acute promyelocytic leukemia.
    Breccia M; Lo Coco F
    Thromb Res; 2014 May; 133 Suppl 2():S112-6. PubMed ID: 24862130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis and management of the bleeding diathesis in acute promyelocytic leukaemia.
    Falanga A; Rickles FR
    Best Pract Res Clin Haematol; 2003 Sep; 16(3):463-82. PubMed ID: 12935963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal treatment strategies for high-risk acute promyelocytic leukemia.
    Norsworthy KJ; Altman JK
    Curr Opin Hematol; 2016 Mar; 23(2):127-36. PubMed ID: 26825698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The coagulopathy in acute promyelocytic leukaemia--what have we learned in the past twenty years.
    Kwaan HC; Cull EH
    Best Pract Res Clin Haematol; 2014 Mar; 27(1):11-8. PubMed ID: 24907013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombomodulin alfa treatment in patients with acute promyelocytic leukemia and disseminated intravascular coagulation: a retrospective analysis of an open-label, multicenter, post-marketing surveillance study cohort.
    Matsushita T; Watanabe J; Honda G; Mimuro J; Takahashi H; Tsuji H; Eguchi Y; Kitajima I; Sakata Y
    Thromb Res; 2014 May; 133(5):772-81. PubMed ID: 24636871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pathophysiology and treatment of hemorrhagic syndrome of acute promyelocytic leukemia.
    Rodeghiero F; Castaman G
    Leukemia; 1994; 8 Suppl 2():S20-6. PubMed ID: 7815832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenesis of disseminated intravascular coagulation in patients with acute promyelocytic leukemia, and its treatment using recombinant human soluble thrombomodulin.
    Ikezoe T
    Int J Hematol; 2014 Jul; 100(1):27-37. PubMed ID: 24217998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coagulopathy of acute promyelocytic leukemia.
    Falanga A; Barbui T
    Acta Haematol; 2001; 106(1-2):43-51. PubMed ID: 11549776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The double hazard of thrombophilia and bleeding in acute promyelocytic leukemia.
    Tallman MS; Abutalib SA; Altman JK
    Semin Thromb Hemost; 2007 Jun; 33(4):330-8. PubMed ID: 17525890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined therapy with all-trans-retinoic acid and high-dose chemotherapy in patients with hyperleukocytic acute promyelocytic leukemia and severe visceral hemorrhage.
    Dombret H; Sutton L; Duarte M; Daniel MT; Leblond V; Castaigne S; Degos L
    Leukemia; 1992 Dec; 6(12):1237-42. PubMed ID: 1453767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical bleeding events and laboratory coagulation profiles in acute promyelocytic leukemia.
    Chang H; Kuo MC; Shih LY; Dunn P; Wang PN; Wu JH; Lin TL; Hung YS; Tang TC
    Eur J Haematol; 2012 Apr; 88(4):321-8. PubMed ID: 22221178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms and management of coagulopathy in acute promyelocytic leukemia.
    David S; Mathews V
    Thromb Res; 2018 Apr; 164 Suppl 1():S82-S88. PubMed ID: 29703489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of paediatric APL: how does the therapeutic approach differ from adults?
    Kutny MA; Gregory J; Feusner JH
    Best Pract Res Clin Haematol; 2014 Mar; 27(1):69-78. PubMed ID: 24907019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.